Top Biotechnology companies in United States by Revenue

This ranking features the top 509 Biotechnology companies in United States ranked by Revenue, totaling a Revenue of USD 647.34 B, for July 03, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Biotechnology company in United States has the highest Revenue ?

The Biotechnology company in United States with the highest Revenue is Merck & Co., Inc. (NYSE: MRK) at USD 63.92 B.

Which Biotechnology company in United States has the lowest Revenue ?

The Biotechnology company in United States with the lowest Revenue is Allogene Therapeutics, Inc. (NasdaqGS: ALLO) at None.

What are the top 10 Biotechnology companies in United States by Revenue ?

The top 10 Biotechnology companies in United States by Revenue are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Gilead Sciences, Inc., Danaher Corporation and Becton, Dickinson and Company.

What are the bottom 10 Biotechnology companies in United States by Revenue ?

The bottom 10 Biotechnology companies in United States by Revenue are Allogene Therapeutics, Inc., Anika Therapeutics, Inc., Aditxt, Inc., Aldeyra Therapeutics, Inc., Autonomix Medical, Inc. Common Stock, Amylyx Pharmaceuticals, Inc., ABVC BioPharma, Inc., Adagio Medical Holdings, Inc., Adverum Biotechnologies, Inc. and Anixa Biosciences, Inc..